Dentin Sensitivity
Conditions
Interventions
n total = 80
G1 - placebo group (2 subgroups) n = 40
Participants should receive the placebo capsules that are given 1 hour before the procedure and every 6 hours for 48 hours.
• G1A: hemiarked (elem
Drug
Other
Sponsors
Universidade Federal do Rio Grande do Norte
Universidade Federal do Rio Grande do Norte
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients should be at least 18 years of age; good general and oral health; upper anterior teeth with no restorations; never bleached before.
Exclusion criteria
Exclusion criteria: Patients who present previous restorations; pregnant or breastfeeding; have discoloration of the dental element caused by trauma; severe fluorosis; darkening caused by endodontic treatment and requiring internal bleaching (non-vital); habits of bruxism or without good oral health; any previous or current health problems (in the stomach, heart, kidney and liver); continuous use of anti-inflammatory drugs and/or analgesics; systemic diseases such as diabetes, hypertension; known allergy to codeine phosphate 30mg/paracetamol 500mg.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Codeine phosphate 30mg/paracetamol 500mg administered 1 hour prior to tooth bleaching and every 6 hours for 48 hours in combination with desensitizing agent may reduce the risk and/or intensity of dental sensitivity levels induced by office bleaching. | — |
Secondary
| Measure | Time frame |
|---|---|
| The coloration of the teeth will not be affected by the tested therapy of codeine phosphate 30mg/paracetamol 500mg in combination with the desensitizer, that is, the effectiveness of the whitening will be maintained. | — |
Countries
Brazil
Contacts
Public ContactIsabela;Kaiza de Araújo;Santos
Universidade Federal do Rio Grande do Norte;Universidade Federal do Rio Grande do Norte
Outcome results
None listed